Pediatric RSV

This lesson is specifically designed to provide healthcare professionals with a deep understanding of the pharmacological management of Respiratory Syncytial Virus (RSV) infections in pediatric patients. RSV is a common and potentially severe respiratory illness in children, and effective pharmacotherapy is essential for optimal patient outcomes. In this lesson, participants will explore evidence-based pharmacological interventions for RSV, including antiviral therapies, bronchodilators, and supportive care measures. Through comprehensive coverage of RSV pharmacotherapy, participants will be prepared to make informed decisions and implement appropriate treatments for pediatric patients with RSV, improving their care in emergency settings.

Learning Objectives:

1. Understand the pathophysiology and clinical presentation of RSV infection in pediatric patients, including the age groups most susceptible to severe illness and potential complications.
2. Demonstrate proficiency in selecting and administering appropriate pharmacological treatments for pediatric RSV, including antiviral agents such as ribavirin, bronchodilators, and supportive measures like oxygen therapy and hydration, while considering patient-specific factors and clinical severity.
3. Recognize the indications, contraindications, potential side effects, and monitoring parameters associated with RSV pharmacotherapy in pediatric patients. Develop the ability to adjust treatment plans based on individual patient responses and evolving clinical conditions to optimize care outcomes.